NFκB, a principal intracellular mediator of pro-inflammatory cytokines, has been proposed as a mechanistic link between inflammation and cancer [47], [48] and its pro-inflammatory signaling targets are activated by both IL1 and TNF. Here, IL1B is linked to cancer.